Endoscopic endonasal surgery for suprasellar craniopharyngiomas
Xuefei Shou,Wenqiang He,Zhao Ye,Zengyi Ma,Ming Shen,Shiqi Li,Yao Zhao,Hongying Ye,Yiming Li,Yongfei Wang
DOI: https://doi.org/10.3760/cma.j.issn.1001-2346.2017.11.005
2017-01-01
Abstract:Objective To explore the endoscopic endonasal approach assisted with various new techniques in the surgical treatment of suprasellar craniopharyngiomas.Methods Nighty-one patients (55 males,36 females) with suprasellar craniopharyngiomas were recruited from September 2012 to December 2016,retrospectively.Endoscopic endonasal trans-tuberculum approach was applied in all patients at Neurosurgery Department of Huashan Hospital,Fudan University.After operation,all patients were asked to take regular follow-up including endocrine exams and sellar contrast MRI.Results Among the 91 cases,53,25 and 13 cases achieved gross-total,subtotal and partial resections,respectively.Other complications included intracranial infection (3 cases) and electrolyte disturbance (3 cases).Sixty-eight (74.7%,68/91) patients obtained anatomic preservation of pituitary stalk postoperatively.Among 62 patients with original visual impairment,35 cases (56.5%,35/62) were improved to different extent.Postoperative complications included cerebrospinal rhinorrhea (3 cases),intracranial infection (3 cases),serious electrolyte disturbance (3 cases),hypothalamic dysfunctions (2 cases),intracranial hemorrhage (2 cases),epistaxis (2 cases) and loss of vision (1 case).All the cases were confirmed craniopharyngiomas pathologically.The follow-up period ranged from 3 months to 54 months (mean:18.0 ±9.7 months).Endocrine exams indicated new-onset hypoadrenalism in 34 cases,hypothyroidism in 30 cases,hypogonadotropic hypogonadism in 15 cases and posterior hypopituitarism in 18 cases.Eight cases with residual tumors underwent radiotherapy and 2 recurrent cases received the second operation during contrast MRI follow-up.Conclusions Endoscopic endonasal surgery demonstrates good results in suprasellar craniopharyngiomas,which is advantageous in facilitation of maximal and safe tumor exposure and protection of the pituitary stalk.